KREMEN2 antibody (C-Term)
Quick Overview for KREMEN2 antibody (C-Term) (ABIN6991832)
Target
See all KREMEN2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 390-440, C-Term
-
Specificity
- Multiple isoforms of KREMEN2 are known to exist. KREMEN2 antibody is predicted to not cross-react with other Kremen protein family members.
-
Purification
- KREMEN2 Antibody is affinity chromatography purified via peptide column.
-
Immunogen
- Anti-KREMEN2 antibody was raised against a peptide corresponding to 14 amino acids near the carboxy terminus of human KREMEN2. The immunogen is located within amino acids 390-440 of KREMEN2.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB: 1-2 μ,g/mL, ICC: 5 μ,g/mL.
Antibody validated: Western Blot in human, mouse and rat samples, Immunocytochemistry in human samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- KREMEN2 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- KREMEN2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
-
-
- KREMEN2 (Kringle Containing Transmembrane Protein 2 (KREMEN2))
-
Alternative Name
- KREMEN2
-
Background
- KREMEN2 Antibody: Kremen (Kringle containing protein marking the eye and the nose) proteins are type I transmembrane proteins that contain extracellular kringle, WSC and CUB domains and an intracellular region without any conserved motifs. Kremens bind a subset of the secreted Dickkopf proteins (Dkk 1, 2, and 4) with high affinity to modulate the canonical Wnt signaling pathway that is transduced by the ternary receptor complex composed of Wnt, Frizzled, and the LDL receptor related protein 5/6 (LRP5/6) co-receptor. Recent experiments have shown that KREMEN2 is a regulator of bone remodeling and raise the possibility that antagonizing KREMEN2 might prove beneficial in patients with bone loss disorders.
-
Molecular Weight
-
Predicted: 49kD
Observed: 49kD kDa -
Gene ID
- 79412
-
NCBI Accession
- NP_757384
-
UniProt
- Q8NCW0
-
Pathways
- WNT Signaling
Target
-